Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Vertes

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
JAMA|May 18, 1979
Ticrynafen and hydrochlorothiazide. A double-blind study of antihypertensive properties with an open crossoverS A Miller, V Vertes
The Urologic Clinics of North America|June 1, 1975
The pathophysiology of renovascular hypertensionV Vertes, M K Ghose
Angiology|December 1, 1979
The massively obese hypertensive patient: an analysis of blood pressure response to weight reduction with supplemented fastingV Vertes, I M Hazelton
Clinical Symposia (Summit, N.J. : 1957)|January 1, 1973
The pathophysiology of reninL B Berman, V Vertes
Primary Care|September 1, 1991
Historical reflections on hypertensionV Vertes, L Tobias, S Galvin
The Mount Sinai Journal of Medicine, New York|September 1, 1988
Clinical utility of nondrug therapy for hypertensionV Vertes, J P Frolkis, P J Martin
JAMA|November 18, 1974
Weight reduction in obesity by outpatient semistarvationS M Genuth, J H Castro, V Vertes
The American Journal of the Medical Sciences|November 1, 1971
Evaluation of select criteria for the diagnosis of primary aldosteronism in normokalemic hypertensionJ L Cangiano, A B Gould, V Vertes
JAMA|November 14, 1977
Supplemented fasting as a large-scale outpatient programV Vertes, S M Genuth, I M Hazelton
JAMA|November 14, 1977
Precautions with supplemented fastingV Vertes, S M Genuth, I M Hazelton
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
JAMA|May 18, 1979
Ticrynafen and hydrochlorothiazide. A double-blind study of antihypertensive properties with an open crossoverS A Miller, V Vertes
The Urologic Clinics of North America|June 1, 1975
The pathophysiology of renovascular hypertensionV Vertes, M K Ghose
Angiology|December 1, 1979
The massively obese hypertensive patient: an analysis of blood pressure response to weight reduction with supplemented fastingV Vertes, I M Hazelton
Clinical Symposia (Summit, N.J. : 1957)|January 1, 1973
The pathophysiology of reninL B Berman, V Vertes
Primary Care|September 1, 1991
Historical reflections on hypertensionV Vertes, L Tobias, S Galvin
The Mount Sinai Journal of Medicine, New York|September 1, 1988
Clinical utility of nondrug therapy for hypertensionV Vertes, J P Frolkis, P J Martin
JAMA|November 18, 1974
Weight reduction in obesity by outpatient semistarvationS M Genuth, J H Castro, V Vertes
The American Journal of the Medical Sciences|November 1, 1971
Evaluation of select criteria for the diagnosis of primary aldosteronism in normokalemic hypertensionJ L Cangiano, A B Gould, V Vertes
JAMA|November 14, 1977
Supplemented fasting as a large-scale outpatient programV Vertes, S M Genuth, I M Hazelton
JAMA|November 14, 1977
Precautions with supplemented fastingV Vertes, S M Genuth, I M Hazelton
Pageof 4